168 related articles for article (PubMed ID: 29771795)
1. The Effect of Peer Support on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary Care.
Kanters AE; Morris AM; Abrahamse PH; Mody L; Suwanabol PA
Dis Colon Rectum; 2018 Jul; 61(7):817-823. PubMed ID: 29771795
[TBL] [Abstract][Full Text] [Related]
2. The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.
Healy MA; Morris AM; Abrahamse P; Ward KC; Kato I; Veenstra CM
BMC Cancer; 2018 Apr; 18(1):481. PubMed ID: 29703172
[TBL] [Abstract][Full Text] [Related]
3. Association of Cumulative Social Risk and Social Support With Receipt of Chemotherapy Among Patients With Advanced Colorectal Cancer.
Davis RE; Trickey AW; Abrahamse P; Kato I; Ward K; Morris AM
JAMA Netw Open; 2021 Jun; 4(6):e2113533. PubMed ID: 34106262
[TBL] [Abstract][Full Text] [Related]
4. Mucinous Histology Signifies Poor Oncologic Outcome in Young Patients With Colorectal Cancer.
Soliman BG; Karagkounis G; Church JM; Plesec T; Kalady MF
Dis Colon Rectum; 2018 May; 61(5):547-553. PubMed ID: 29578919
[TBL] [Abstract][Full Text] [Related]
5. Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials.
Kanda M; Oba K; Aoyama T; Kashiwabara K; Mayanagi S; Maeda H; Honda M; Hamada C; Sadahiro S; Sakamoto J; Saji S; Yoshikawa T;
Dis Colon Rectum; 2018 Apr; 61(4):461-471. PubMed ID: 29521828
[TBL] [Abstract][Full Text] [Related]
6. A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.
Lindskog EB; Gunnarsdóttir KÁ; Derwinger K; Wettergren Y; Glimelius B; Kodeda K
BMC Cancer; 2014 Dec; 14():948. PubMed ID: 25495897
[TBL] [Abstract][Full Text] [Related]
7. Treatment and referral patterns for colorectal cancer.
Oliveria SA; Yood MU; Campbell UB; Yood SM; Stang P
Med Care; 2004 Sep; 42(9):901-6. PubMed ID: 15319616
[TBL] [Abstract][Full Text] [Related]
8. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.
Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM
Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196
[TBL] [Abstract][Full Text] [Related]
9. Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients.
Lund JL; Stürmer T; Sanoff HK; Brookhart A; Sandler RS; Warren JL
Cancer; 2013 Jun; 119(11):2038-47. PubMed ID: 23512326
[TBL] [Abstract][Full Text] [Related]
10. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
11. Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer.
Hendren S; Birkmeyer JD; Yin H; Banerjee M; Sonnenday C; Morris AM
Dis Colon Rectum; 2010 Dec; 53(12):1587-93. PubMed ID: 21178851
[TBL] [Abstract][Full Text] [Related]
12. Understanding Patients' Experiences of Diagnosis and Treatment of Advanced Colorectal Cancer in a Safety-Net Hospital System: A Qualitative Study.
Leal IM; Kao LS; Karanjawala B; Escamilla RJ; Ko TC; Millas SG
Dis Colon Rectum; 2018 Apr; 61(4):504-513. PubMed ID: 29521833
[TBL] [Abstract][Full Text] [Related]
13. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.
Ayanian JZ; Zaslavsky AM; Fuchs CS; Guadagnoli E; Creech CM; Cress RD; O'Connor LC; West DW; Allen ME; Wolf RE; Wright WE
J Clin Oncol; 2003 Apr; 21(7):1293-300. PubMed ID: 12663717
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?
Madbouly KM; Hussein AM; Zeid A
Dis Colon Rectum; 2013 May; 56(5):577-85. PubMed ID: 23575396
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.
Mayanagi S; Kashiwabara K; Honda M; Oba K; Aoyama T; Kanda M; Maeda H; Hamada C; Sadahiro S; Sakamoto J; Saji S; Yoshikawa T
Dis Colon Rectum; 2018 Jul; 61(7):803-808. PubMed ID: 29561282
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group.
Keikes L; van Oijen MGH; Lemmens VEPP; Koopman M; Punt CJA
Clin Colorectal Cancer; 2018 Mar; 17(1):58-64. PubMed ID: 29157662
[TBL] [Abstract][Full Text] [Related]
17. Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.
Antonio M; Carmona-Bayonas A; Saldaña J; Navarro V; Tebé C; Salazar R; Borràs JM
Clin Colorectal Cancer; 2018 Mar; 17(1):e59-e68. PubMed ID: 29054805
[TBL] [Abstract][Full Text] [Related]
18. Influence of Anastomotic Leak After Elective Colorectal Cancer Resection on Survival and Local Recurrence: A Propensity Score Analysis.
Zimmermann MS; Wellner U; Laubert T; Ellebrecht DB; Bruch HP; Keck T; Schlöricke E; Benecke CR
Dis Colon Rectum; 2019 Mar; 62(3):286-293. PubMed ID: 30540662
[TBL] [Abstract][Full Text] [Related]
19. The impact of anastomotic leakage on oncologic outcomes and the receipt and timing of adjuvant chemotherapy after colorectal cancer surgery.
Kim IY; Kim BR; Kim YW
Int J Surg; 2015 Oct; 22():3-9. PubMed ID: 26283295
[TBL] [Abstract][Full Text] [Related]
20. The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma.
Zhao Z; Yan N; Pan S; Wang DW; Li ZW
Sci Rep; 2020 Aug; 10(1):14126. PubMed ID: 32839528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
